Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Menopause. 2010 Jan;17(1):178–184. doi: 10.1097/gme.0b013e3181afcce5

Figure 1.

Figure 1

Figure 1

(A) Curcumin delays MPA-accelerated tumorigenesis. Animals were palpated 2-3 times each week and tumors were measured. Latency period differences were compared using a general linear model (PROC GENMOD in SAS) in which the link function was logit and the distribution was binomial. MPA treated DMBA-induced animals were 2.2 times more likely to develop tumors than animals given DMBA alone and 4.4 times more likely than animals given curcumin alone or placebo (n= 15-19/group). (B) Tumor Multiplicity. The average number of tumors per tumor-bearing animal at the conclusion of the study was 1.9 for MPA-treated animals and 1 for Control, MPA + Curcumin and Curcumin alone. *Significantly different from the rest of the groups (ANOVA, p<0.05), Errors bars represent SEM.